MNOV
MNOV
NASDAQ · Biotechnology

Medicinova Inc

$2.10
-0.48 (-18.60%)
As of Sep 28, 10:25 PM ET ·
Financial Highlights (FY 2026)
Revenue
421.2K
Net Income
-12,407,759
Gross Margin
7.6%
Profit Margin
-2,928.8%
Rev Growth
—
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 7.6% 36.9% 36.9% 36.9%
Operating Margin -3,242.4% -6.1% -6.2% -5.2%
Profit Margin -2,928.8% -4.9% -5.0% -5.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 421.2K 11.04M 11.56M 10.16M
Gross Profit 31.9K 4.07M 4.26M 3.74M
Operating Income -13,657,286 -678,619 -711,893 -528,734
Net Income -12,407,759 -536,425 -578,623 -557,404
Gross Margin 7.6% 36.9% 36.9% 36.9%
Operating Margin -3,242.4% -6.1% -6.2% -5.2%
Profit Margin -2,928.8% -4.9% -5.0% -5.5%
Rev Growth — +9.7% -0.5% +16.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 32.67M 29.36M 29.97M
Total Equity — 34.04M 33.10M 34.09M
D/E Ratio — 0.96 0.89 0.88
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -13,717,044 -810,707 -735,622 -650,086
Free Cash Flow — -370,627 -351,629 -405,371